One study found that cardiac biomarkers, namely N-terminal pro-b-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin (hs-cTn), were prognostic in systemic light chain amyloidosis (AL) patients without cardiac involvement by standard criteria. Here, NPPB is linked to axial length measurement.